Research & Publishing

Dr. Christian Thurstone reveres research, and he’s grateful for every opportunity he has to incorporate it into his practice of medicine. In addition to conducting research, he currently serves as a reviewer for the following medical journals:

Dr. Thurstone is also a big believer in transparency. He wants you to know how his research is funded — and what the money invested in his work has helped produce.

 

 

 

Ongoing Research Support

Role: PI Funding Source & Grant Number:NIDA 5 P60 DA011015 Dates: 5/1/09-2/28/14 Effort: 8 percent Total Directs: $46,680

This grant, titled Genetics of Antisocial Drug Dependence, will evaluate the genetic risk factors of HIV risk behavior among youth in substance treatment. The grant is funded by the National Institutes of Health/National Institute on Drug Abuse, and the principal investigator is Dr. John Hewitt at the University of Colorado Boulder. For more about the researchers, see the Center for Anti-Social Drug Dependence.

Role: Co-I Funding Source and Grant Number: NIDA 3 U10DA013045-11S3 Dates: 5/1/2011-8/31/2015 Effort: 20% Total Directs: $239,625

This multi-site trial, titled Cocaine Use Reduction with Buprenorphine, will evaluate the effectiveness of buprenorphine/injectable naltrexone compared to placebo/injectable naltrexone for cocaine dependence. The grant is funded by the National Institutes of Health/National Institute on Drug Abuse, and the principal investigator is Dr. Walter Ling at the University of California Los Angeles.

Role: Co-I Funding Source and Grant Number: NIDA 1 R01DA031816-01A1 Dates: 9/1/2011-8/31/2016 Effort: 20% Total Directs: $239,625

This grant, titled The Impact of Medical Marijuana in Metropolitan Denver, will evaluate the impact of medical marijuana on variables such as prevalence of marijuana use, substance treatment admissions and emergency department visits using qualitative and quantitative research methods. The grant is funded by the National Institutes of Health/National Institute on Drug Abuse, and the principal investigator is Dr. Robert Booth at the University of Colorado Denver.

 

Completed Research Support

Role: PI Funding Source and Grant Number: NIDA 2 P60 DA011015-06A Dates: 5/01/04 – 1/31/05 Effort: 10 percent Total Directs: $25,000

This study, titled Ibuprofen for Adolescent Cannabis Dependence, evaluated the preliminary safety and feasibility of ibuprofen for adolescent cannabis dependence. The study was funded by the National Institutes of Health/National Institute on Drug Abuse, and the principal investigator was Dr. Christian Thurstone.

Role: PI Funding Source and Grant Number: NIH NOT-OD-02-025 Dates: 7/01/03 – 6/01/05 Effort: 75 percent Total Directs: $92,000

This grant, titled Medication Development for Adolescent Substance Use Disorders, was a loan repayment program for conducting mentored clinical research in child psychiatry. The grant was funded by the National Institutes of Health/National Institute on Drug Abuse, and the principal investigator was Dr. Christian Thurstone.

Role: PI Funding Source and Grant Number: NIDA DA 000357-06A1K12 Dates: 7/01/05-5/15/10 Effort: 75 percent Total Directs: $773,095

This study, titled Atomoxetine for ADHD in Adolescents with Substance Use Disorders, evaluated the efficacy of atomoxetine for ADHD in adolescents presenting for substance treatment. The grant was funded by the National Institutes of Health/National Institute on Drug Abuse, and the principal investigator was Dr. Christian Thurstone.

 

Peer-Reviewed Publications

Dr. Thurstone’s clinical work and medical research have resulted in several papers published in peer-reviewed journals. Among them:

Thurstone CC, Alahi P (2000), “A possible case of quetiapine withdrawal syndrome [letter].” Journal of Clinical Psychiatry 61: 602-603

Davies RD, Thurstone C, Woyewodzic K (2004), Substance Use Disorders and Neurologic Illness. Current Treatment Options in Neurology 6: 421-432

Ritvo JL, Koonce R, Thurstone CC, Causey HL 3rd (2007), Tramadol dependence: treatment with buprenorphine/naloxone. American Journal of Addiction 16:67-68

Thurstone C, Riggs PD, Klein C, Mikulich-Gilbertson SK (2007), A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. Journal of American Academy of Child and Adolescent Psychiatry 46:1179-1186

Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK (2010), Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. Journal of American Academy of Child and Adolescent Psychiatry 49:573-582

Thurstone C, Salomonsen-Sautel S, Riggs PD (2010), How teens with substance use disorder spend research payments. Drug Alcohol Dependence 111:262-264

Thurstone C, Liebmeran SA, Schmiege SJ (2011), Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Dependence

Nussbaum AM, Thurstone C, Binswanger I (2011), Medical marijuana use and suicide attempt in a patient with major depressive disorder. Am J Psychiatry 168:778-781

Nussbaum AM, Thurstone C (2011), “Mile High Macaroons; The Medicalization of Marijuana in Colorado.” Journal of Global Drug Policy and Practice 5:5-15

Salomonsen-Sautel S, Sakai JT, Thurstone C, Corley R, Hopfer C (2012), “Medical Marijuana Use Among Adolescents in Substance Abuse Treatment.” Journal of the American Academy of Child & Adolescent Psychiatry, Volume 51, Issue 7, Pages 694-702

 

Scientific Abstracts

The following scientific abstracts were competitively peer-reviewed and published or presented at scientific meetings:

Thurstone CC, Teitsworth SW (1991), “Quantum chaos effects in an irregular drumhead.” Bulletin of the American Physical Society 36: 2746

Thurstone CC, Teitsworth SW (1992) Unstable periodic orbits and chaotic spectra in an irregularly-shaped drumhead. Bulletin of the American Physical Society 37: 268

Thurstone C, Riggs PD, Mikulich-Gilbertson SK (2004), “Assessment of Nicotine Dependence in Adolescents.” Oral presentation at the annual meeting of the College in Problems of Drug Dependence, San Juan, Puerto Rico

Thurstone C, Riggs PD, Mikulich-Gilbertson SK (2004), “Evaluation of the Fagerstrom Test of Nicotine Dependence in Adolescence.” Poster presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry. Washington, DC

Thurstone C, Riggs PD, Orton HD, Libby AM (2005), “Fluoxetine and cannabis withdrawal in depressed adolescents.” Poster presentation at the annual meeting of the College in Problems of Drug Dependence, Orlando, Florida

Thurstone C, Riggs PD, Schwab S (2005), “Adoption of an evidence-based treatment for adolescent substance use disorder.” Poster presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada

Thurstone C, Riggs PD, Wackwitz J (2006), “Pilot safety and feasibility study of ibuprofen for adolescent cannabis dependence.” Oral presentation at the annual meeting of the College in Problems of Drug Dependence, Scottsdale, AZ

Thurstone C, Riggs PD (2006), “Adoption and benchmarking of an evidence-based treatment for adolescent substance use disorder.” Poster presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, San Diego, CA

Thurstone C (2007), “Adolescent heroin abuse.” Oral presentation at the annual meeting of the Society for Adolescent Medicine, Denver, CO

Thurstone C, Riggs PD, Klein C, Stover SK, Mikulich-Gilbertson SK (2007) “The relationship between cannabis and nicotine use in adolescent substance use disorder treatment.” Presented at the annual meeting of the College in Problems of Drug Dependence, Quebec, Canada

Thurstone C (2007), “Implementing the “Fishbowl” into a Community Setting.” Oral presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Boston, MA

Thurstone C (2007), “Adopting an Integrated Treatment Model into a Community Setting.” Oral presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Boston, MA

Thurstone C, M deDios, PD Riggs (2007), “How teens with substance use disorder spend research payments.” Poster presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Boston, MA

Lott DC, Thurstone C (2008), “Varenicline for Adolescent Smoking: Preliminary Case Data.” Poster presentation at the annual meeting of the College in Problems of Drug Dependence, San Juan, Puerto Rico

Thurstone C, Riggs PD, Salomonsen-Sautel S (2008), “The relationship between change in cannabis and change in nicotine use among teens in treatment for cannabis.” Poster presentation at the annual meeting of the College in Problems of Drug Dependence, San Juan, Puerto Rico

Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK (2008), “Randomized, placebo-controlled trial of atomoxetine for ADHD in adolescents with substance use disorder.” Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL

Thurstone C, Riggs PD, Mikulich-Gilbertson SK (2008), Results from a one-session HIV intervention for adolescents with psychiatric and substance use disorders. Oral presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL

Salomonsen-Sautel S, Mikulich-Gilbertson SK, Riggs PD, Thurstone C (2009), Neighborhood disadvantage and substance use among adolescents. Poster presentation at the annual meeting of the College in Problems of Drug Dependence, Reno, NV

Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK (2009), One-session HIV prevention intervention for teens in substance use disorder treatment. Poster presentation at the annual meeting of the College in Problems of Drug Dependence, Reno, NV

Thurstone C, Salomonsen-Sautel S, Hartman C, Stallings M, Crowley TJ, Sakai J, Hoffenberg A, Corley R, Mikulich-Gilbertson S, Young S, McQueen M, Hewitt J, Hopfer CJ (2011), Longitudinal HIV risk in youth referred to substance treatment. Oral presentation at the annual meeting of the College in Problems of Drug Dependence, Hollywood, FL

Thurstone C (2011), “Medical marijuana in Colorado and its impact on youth.” Oral presentation at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada

 

Non Peer-Reviewed Publications

Book reviews

Thurstone C (2003), Children with Autism and Asperger Syndrome: A guide for Practitioners and Carers, by Patricia Howlin [Book Review]. Residential Treatment for Children and Youth 21: 71-73

Martin A, Thurstone C (2007), Adolescent Substance Abuse: Research and Clinical Advances, by Liddle and Rowe [Book Review]. J Am Acad of Child Adolesc Psychiatry 46:547-548

Media Publications

Thurstone, C (2009 -Present), “Talk 2 Me.” Weekly advice column in The Mash, a high school newspaper published by the Chicago Tribune and distributed to more than 200,000 high school students in metro Chicago

Thurstone C (2010), “Smoke and Mirrors.” Denver Health Perspectives Piece, published January 31, 2010

Thurstone C (2010), “We must regulate medical marijuana.” Denver Post Opinion Piece, co-written with Colorado state Sen. Chris Romer

Thurstone C (2010), “Marijuana and Youth – Experiences from a practicing physician.” Of Substance Blog, Office of National Drug Control Policy

Professional Society Publications

Thurstone C (2011), “Spice.” Article written for the quarterly newsletter of the Colorado Child and Adolescent Psychiatric Society

Thurstone C (2011), “Why child psychiatrists should oppose legalizing marijuana.” Article written for the quarterly newsletter of the Colorado Child and Adolescent Psychiatric Society

 

Social Widgets powered by AB-WebLog.com.